Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effects of DNHS Technique in the Treatment of Upper Limb Spasticity and Function in Stroke

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02291159
Recruitment Status : Completed
First Posted : November 14, 2014
Last Update Posted : December 31, 2014
Sponsor:
Information provided by (Responsible Party):
Pablo Herrero Gallego, Universidad San Jorge

Brief Summary:
Introduction: Stroke is a neurological deficit caused by a decrease in cerebral blood flow. The DNHS ® (Dry Needling for hypertonia and Spasticity) technique is a dry needling technique to reduce spasticity and hypertonia and improve function in patients with CNS injury. The main objective of this trial is to analyze the therapeutic effect of DNHS® technique in motor function in patients between 45 and 80 in a chronic state after a stroke. Methods: Double-blinded randomized clinical trial. There will be an intervention group (DNHS® technique) and a sham control group. The intervention will be 2 sessions, one per week, in biceps brachii, brachialis, flexor digitorum superficialis nad profundus, adductor pollicis and first dorsal interossei. The Fugl Meyer Assessment Scale, Modified Ashworth Scale and Stroke Impact Scale will be used as outcome measures. The data will be expressed as mean ± (Standard Deviation). The standardized difference or effect size (ES, 90% confidence limit) in the selected variables will be calculated.

Condition or disease Intervention/treatment Phase
Stroke Spasticity Device: DNHS ® (Dry Needling for Hypertonia and Spasticity) Device: Sham Dry Needling Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 10 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Effectiveness of Dry Needling (DNHS Technique) in the Treatment of Upper Limb Spasticity and Function in Stroke Patients: a Randomized Clinical Trial
Study Start Date : November 2014
Actual Primary Completion Date : December 2014
Actual Study Completion Date : December 2014

Arm Intervention/treatment
Experimental: Intervention-DNHS technique
Dry needling of Myofascial Trigger Points
Device: DNHS ® (Dry Needling for Hypertonia and Spasticity)
Dry needling of Myofascial Trigger Points. 2 sessions, one per week, in biceps brachii, brachialis, flexor digitorum superficialis nad profundus, adductor pollicis and first dorsal interossei

Sham Comparator: Control-Sham Dry Needling
Sham Dry Needling of Myofascial Trigger Points
Device: Sham Dry Needling
Sham dry needling of Myofascial Trigger Points. 2 sessions, one per week, in biceps brachii, brachialis, flexor digitorum superficialis nad profundus, adductor pollicis and first dorsal interossei




Primary Outcome Measures :
  1. Fugl Meyer Assessment Scale (Motor Function) [ Time Frame: Two weeks ]

Secondary Outcome Measures :
  1. Modified Ashworth Scale (Hypertonia/Spasticity) [ Time Frame: Two weeks ]
  2. Impact Stroke Scale (Quality of Life) [ Time Frame: Two weeks ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   40 Years to 85 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • people aged 40-85 years with hemiplegia resulting from stroke of more than 6 months evolution (chronic stroke)
  • ability to follow instructions and reply to assessment questonnaires

Exclusion Criteria:

  • recurrent stroke episodes
  • other concomitant neurodegenerative conditions
  • fear to needles
  • participation in a parallel study
  • any absolute contraindication for deep dry needling

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02291159


Locations
Layout table for location information
Spain
San Jorge University
Villanueva de Gallego, Zaragoza, Spain, 50830
Sponsors and Collaborators
Universidad San Jorge
Investigators
Layout table for investigator information
Study Director: Herrero Pablo, Dr. San Jorge University

Layout table for additonal information
Responsible Party: Pablo Herrero Gallego, Dr. Pablo Herrero Gallego, Universidad San Jorge
ClinicalTrials.gov Identifier: NCT02291159     History of Changes
Other Study ID Numbers: USJ_DNHS_UL_01
First Posted: November 14, 2014    Key Record Dates
Last Update Posted: December 31, 2014
Last Verified: December 2014

Keywords provided by Pablo Herrero Gallego, Universidad San Jorge:
stroke
spasticity
dry needling
upper motor neuron syndrome
motor function

Additional relevant MeSH terms:
Layout table for MeSH terms
Stroke
Muscle Spasticity
Cerebrovascular Disorders
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Vascular Diseases
Cardiovascular Diseases
Muscular Diseases
Musculoskeletal Diseases
Muscle Hypertonia
Neuromuscular Manifestations
Neurologic Manifestations
Signs and Symptoms